Back
ProShares Short 20+ Yr Treasury Vs. Corcept Therapeutics, Inc. Industry Stock Comparison
Buy
62
TBF
ProShares Short 20+ Yr Treasury
Last Price:
$23.92
Seasonality Move:
-0.66%
Sell
36
CORT
Corcept Therapeutics, Inc.
Last Price:
$37.74
Seasonality Move:
6.8%
Buy
62
ProShares Short 20+ Yr Treasury (TBF)
is a Buy
Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?
-
The current ProShares Short 20+ Yr Treasury [TBF] share price is $23.89. The Score for TBF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
TBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Corcept Therapeutics, Inc. [CORT] share price is $70.20. The Score for CORT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBF Stock Price Chart
What is ProShares Short 20+ Yr Treasury's stock price today?
-
The ProShares Short 20+ Yr Treasury share price today is $23.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics, Inc.'s stock price today?
-
The Corcept Therapeutics, Inc. share price today is $70.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
TBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.65 | Buy |
| Relative Strength Index (14 RSI): | 47.24 | Sell |
| Chaikin Money Flow: | -33774 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.72 - 24.2) | Sell |
| Bollinger Bands (100): | (23.45 - 24.33) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 32.16 | Sell |
| Chaikin Money Flow: | -2244663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.7 - 85.94) | Sell |
| Bollinger Bands (100): | (71.38 - 83.18) | Sell |
TBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.04 | Sell |
| 20-day SMA: | 24.05 | Sell |
| 50-day SMA: | 23.72 | Buy |
| 200-day SMA: | 24.2 | Sell |
| 8-day EMA: | 20.76 | Buy |
| 20-day EMA: | 13.23 | Buy |
| 50-day EMA: | 6.58 | Buy |
| 200-day EMA: | 1.85 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.08 | Sell |
| 20-day SMA: | 83.06 | Sell |
| 50-day SMA: | 78.49 | Sell |
| 200-day SMA: | 74.04 | Sell |
| 8-day EMA: | 79.79 | Sell |
| 20-day EMA: | 81.21 | Sell |
| 50-day EMA: | 78.92 | Sell |
| 200-day EMA: | 51.36 | Buy |
ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $3.11 per share.
ProShares Short 20+ Yr Treasury Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||